CX3CR1 identifies PD-1 therapy-responsive CD8+ T cells that withstand chemotherapy during cancer chemoimmunotherapy

Authors
Yan Y.1 , Adjei A.A. 1, 3 , Mansfield A.S.1 , Markovic S.N.1 , Dronca R.S.1 , Cao S.2 , Liu X.2 , Harrington S.M.2 , Bindeman W.E.2 , Dong H.2, 7 , Jang J.S.4 , Jen J.4 , Li Y.5 , Chanana P.5 , Park S.S.6
Editors
-
Journal
Publisher
-
Number of issue
8
Language
English
Pages
-
Status
Published
Department
-
Link
-
Number
-
Volume
3
Year
2018
Organizations
  • 1 Division of Medical Oncology
  • 2 Mayo Clinic Cancer Center Early Therapeutic Program
  • 3 Department of Urology
  • 4 Department of Immunology|Mayo Clinic
  • 5 Mayo Clinic Center of Individualized Medicine
  • 6 Department of Biomedical Statistics and Informatics
  • 7 Department of Radiation Oncology
Keywords
-
Date of creation
07.11.2019
Date of change
07.11.2019
Short link
https://repository.rudn.ru/en/records/article/record/50570/